Macquarie Group Ltd
- SEC CIK
- 0001418333
- Latest filing
- Aug 14, 2026
JANX holding history
Janux Therapeutics, Inc. in every 13F filed by Macquarie Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
JANX overviewAll 13F holders of JANXFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −76,601−100.0% | Sold out | Holders |
| Q3 2025 | 76,601 | $1.87M | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 76,601 | $1.77M | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 76,601 | $2.07M | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 76,601 | $4.10M | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 76,601 | $3.48M | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 76,601 | $3.21M | <0.1% | +16,601+27.7% | Added | Holders |
| Q1 2024 | 60,000 | $2.26M | <0.1% | +60,000 | New | Holders |